Annexon Biosciences granted stock options to six new non-executive employees as inducements under its 2022 Employment Inducement Award Plan. The options cover 1,270,000 shares at an exercise price of $3.60, reflecting the stock's closing price on October 15, 2026. These options vest over four years, incentivizing employee retention and aligning interests with shareholders. This move supports Annexon's growth in developing targeted immunotherapies for neuroinflammatory diseases affecting millions globally.
Annexon Biosciences' inducement grants to new employees provide context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 17, 2026 04:11 WIB: Of 150 priced US health-sector stocks tradable on Pluang, 44 rose and 106 fell today. Notable movers include SELLAS Life Sciences Group Inc. (SLS) at USD 10.01 with a 1-day change of -11.73% and a typical hold time of 2 days, Erasca Inc. (ERAS) at USD 13.45 down 9.58% with a 2-day hold, and GeneDx Holdings Corp (WGS) at USD 63.51 down 9.56%, with a 20-day hold time and Pluang order activity showing 100% sell and 0% buy.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
